Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practice

Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practice

BackgroundNausea and vomiting are common side effects of Trastuzumab Deruxtecan (T-DXd), but guidelines for optimal management were not initially available. This retrospective single-center study aimed at evaluating the efficacy of two antiemetic regimens in patients receiving T-DXd.MethodsData from...

Full description

Bibliographic Details
Main Authors: Giulia Notini, Matteo Maria Naldini, Lorenzo Sica, Giulia Viale, Alessia Rognone, Stefania Zambelli, Patrizia Zucchinelli, Marta Piras, Carlo Bosi, Marco Mariani, Daniela Aldrighetti, Giampaolo Bianchini, Luca Licata
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Oncology
Subjects:
nausea
vomiting
antiemetic prophylaxis
Trastuzumab Deruxtecan
breast cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1374547/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1374547/full

Similar Items